Posard Matthew L.

EDGAR CIK 0001543792

Halozyme Therapeutics, Inc. - HALO

  1. Manufacturing
  2. Chemicals
  3. Biological Products, (no Disgnostic Substances)
Director
Direct Buys
0
$0
0 Shares
Direct Sells
2
($2.61) M
-24,226 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
10/01/2026
10b5-1
10/02/2026
Sell
-5,230 @ $108.54
 ($567,661) 53,609 (-8.89%) Direct
09/16/2026
10b5-1
09/17/2026
Sell
-18,996 @ $107.74
 ($2,046,581) 58,839 (-24.41%) Direct